Novo Nordisk shrugs off Brexit, unveils $144M plan for a diabetes research center at Oxford
Brexit may have raised concerns about the future of academic research in the UK, but it didn’t stop Novo Nordisk from pushing ahead with plans …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
